EP0702516A4
(en)
*
|
1993-06-01 |
1998-04-22 |
Life Technologies Inc |
GENETIC IMMUNIZATION WITH CATIONIC LIPIDS
|
US5674908A
(en)
*
|
1993-12-20 |
1997-10-07 |
Life Technologies, Inc. |
Highly packed polycationic ammonium, sulfonium and phosphonium lipids
|
FR2714830B1
(fr)
|
1994-01-10 |
1996-03-22 |
Rhone Poulenc Rorer Sa |
Composition contenant des acides nucléiques, préparation et utilisations.
|
US6989434B1
(en)
|
1994-02-11 |
2006-01-24 |
Invitrogen Corporation |
Reagents for intracellular delivery of macromolecules
|
US5747471A
(en)
*
|
1994-12-09 |
1998-05-05 |
Genzyme Corporation |
Cationic amphiphiles containing steroid lipophilic groups for intracellular delivery of therapeutic molecules
|
US5650096A
(en)
*
|
1994-12-09 |
1997-07-22 |
Genzyme Corporation |
Cationic amphiphiles for intracellular delivery of therapeutic molecules
|
US6071890A
(en)
*
|
1994-12-09 |
2000-06-06 |
Genzyme Corporation |
Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
|
US6331524B1
(en)
|
1994-12-09 |
2001-12-18 |
Genzyme Corporation |
Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy
|
US5948767A
(en)
*
|
1994-12-09 |
1999-09-07 |
Genzyme Corporation |
Cationic amphiphile/DNA complexes
|
US5719131A
(en)
*
|
1994-12-09 |
1998-02-17 |
Genzyme Corporation |
Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules
|
US5840710A
(en)
*
|
1994-12-09 |
1998-11-24 |
Genzyme Corporation |
Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules
|
US6383814B1
(en)
|
1994-12-09 |
2002-05-07 |
Genzyme Corporation |
Cationic amphiphiles for intracellular delivery of therapeutic molecules
|
US5767099A
(en)
*
|
1994-12-09 |
1998-06-16 |
Genzyme Corporation |
Cationic amphiphiles containing amino acid or dervatized amino acid groups for intracellular delivery of therapeutic molecules
|
US5910487A
(en)
*
|
1994-12-09 |
1999-06-08 |
Genzyme Corporation |
Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules
|
US6630455B1
(en)
|
1995-01-13 |
2003-10-07 |
Vanderbilt University |
Methods for inducing mucosal immune responses
|
US6008202A
(en)
*
|
1995-01-23 |
1999-12-28 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
US20030069173A1
(en)
*
|
1998-03-16 |
2003-04-10 |
Life Technologies, Inc. |
Peptide-enhanced transfections
|
US5855911A
(en)
*
|
1995-08-29 |
1999-01-05 |
Board Of Regents, The University Of Texas System |
Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
|
EP0863749A2
(en)
*
|
1995-11-30 |
1998-09-16 |
Vical Incorporated |
Complex cationic lipids
|
US6297198B1
(en)
*
|
1996-05-14 |
2001-10-02 |
Syngenta Participations Ag |
Isoxazole derivatives and their use as herbicides
|
US5935936A
(en)
*
|
1996-06-03 |
1999-08-10 |
Genzyme Corporation |
Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
|
US7309692B1
(en)
*
|
1996-07-08 |
2007-12-18 |
Board Of Regents, The University Of Texas System |
Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
|
US6977244B2
(en)
|
1996-10-04 |
2005-12-20 |
Board Of Regents, The University Of Texas Systems |
Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
|
US5962429A
(en)
*
|
1996-11-22 |
1999-10-05 |
University Of Iowa |
Complexes of adenovirus with cationic molecules
|
US6511477B2
(en)
*
|
1997-03-13 |
2003-01-28 |
Biocardia, Inc. |
Method of drug delivery to interstitial regions of the myocardium
|
US6443949B2
(en)
*
|
1997-03-13 |
2002-09-03 |
Biocardia, Inc. |
Method of drug delivery to interstitial regions of the myocardium
|
US5925628A
(en)
*
|
1997-03-31 |
1999-07-20 |
Genzyme Corporation |
Cationic amphiphiles for intracellular delivery of therapeutic molecules
|
US5912239A
(en)
*
|
1997-04-04 |
1999-06-15 |
Genzyme Corporation |
Imidazole-containing cationic amphiphiles for intracellular delivery of therapeutic molecules
|
US5948925A
(en)
*
|
1997-05-06 |
1999-09-07 |
Genzyme Corporation |
Cationic amphiphiles containing linkers derived from neutral or positively charged amino acids
|
US5952516A
(en)
*
|
1997-05-08 |
1999-09-14 |
Genzyme Corporation |
Cationic amphiphiles containing multiplesteroid lipophilic groups
|
US5942634A
(en)
*
|
1997-05-09 |
1999-08-24 |
Genzyme Corporation |
Cationic amphiphiles for cell transfections
|
FR2766706B1
(fr)
*
|
1997-07-30 |
2001-05-25 |
Biovector Therapeutics Sa |
Complexes particulaires stables de charge globale neutre ou negative de structure multilamellaire composes par au moins une substance biologiquement active globalement anionique et un constituant cationique, leur preparation et utilisation
|
US7285288B1
(en)
|
1997-10-03 |
2007-10-23 |
Board Of Regents, The University Of Texas System |
Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
|
US7704962B1
(en)
|
1997-10-03 |
2010-04-27 |
Board Of Regents, The University Of Texas System |
Small oligonucleotides with anti-tumor activity
|
US6410328B1
(en)
*
|
1998-02-03 |
2002-06-25 |
Protiva Biotherapeutics Inc. |
Sensitizing cells to compounds using lipid-mediated gene and compound delivery
|
US7060479B2
(en)
*
|
1999-12-08 |
2006-06-13 |
Serono Genetics Institute, S.A. |
Full-length human cDNAs encoding potentially secreted proteins
|
US7223727B2
(en)
*
|
1998-04-09 |
2007-05-29 |
Serono Genetics Institute S.A. |
GSSP4 polynucleotides and polypeptides and uses thereof
|
EP0996739A2
(en)
*
|
1998-05-06 |
2000-05-03 |
Transgene S.A. |
Improvments in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10
|
EP1086699B1
(en)
*
|
1998-05-25 |
2010-07-14 |
Nippon Shinyaku Co., Ltd. |
Process for producing composite preparation containing nucleic acid
|
NZ512244A
(en)
*
|
1998-11-12 |
2003-12-19 |
Invitrogen Corp |
Polycationic transfection reagents for introducing anions into a cell
|
US6570003B1
(en)
*
|
2001-01-09 |
2003-05-27 |
Lexion Genetics Incorporated |
Human 7TM proteins and polynucleotides encoding the same
|
US6514762B1
(en)
|
1999-04-23 |
2003-02-04 |
New Mexico State University Technology Transfer Corporation |
Delivery of nucleotides by electrochemical release
|
US6379930B1
(en)
*
|
1999-07-30 |
2002-04-30 |
Applied Gene Technologies, Inc. |
Stabilization of nucleic acid amplification cocktails
|
US20020161214A1
(en)
*
|
2000-11-01 |
2002-10-31 |
Walke D. Wade |
Novel human proteases and polynucleotides encoding the same
|
US6448388B1
(en)
|
2000-08-16 |
2002-09-10 |
Lexicon Genetics Incorporated |
Human proteases and polynucleotides encoding the same
|
US20080003673A1
(en)
*
|
1999-09-02 |
2008-01-03 |
Alejandro Abuin |
Novel human proteases and polynucleotides encoding the same
|
US20030050464A1
(en)
*
|
2000-07-28 |
2003-03-13 |
Yi Hu |
Novel human proteases and polynucleotides encoding the same
|
US20020049312A1
(en)
*
|
2000-05-23 |
2002-04-25 |
Turner C. Alexander |
Noel human thrombospondin-like proteins and polynucleotides encoding the same
|
US6716614B1
(en)
*
|
1999-09-02 |
2004-04-06 |
Lexicon Genetics Incorporated |
Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof
|
US20050153323A1
(en)
*
|
2000-07-28 |
2005-07-14 |
Yi Hu |
Novel human proteases and polynucleotides encoding the same
|
US7374933B2
(en)
*
|
2000-04-12 |
2008-05-20 |
Lexicon Pharmaceuticals, Inc. |
Human metalloprotease and polynucleotides encoding the same
|
US6867291B1
(en)
*
|
2000-09-15 |
2005-03-15 |
Lexicon Genetics Incorporated |
Human hemicentin proteins and polynucleotides encoding the same
|
US20030028907A1
(en)
*
|
2001-07-03 |
2003-02-06 |
Walke D. Wade |
Novel human kielin-like proteins and polynucleotides encoding the same
|
US6790660B1
(en)
|
2001-09-18 |
2004-09-14 |
Lexicon Genetics Incorporated |
Human kielin-like proteins and polynucleotides encoding the same
|
US20020107382A1
(en)
*
|
2000-09-27 |
2002-08-08 |
Friddle Carl Johan |
Novel human protease inhibitor proteins and polynucleotides encoding the same
|
US20030166883A1
(en)
*
|
2000-11-15 |
2003-09-04 |
Walke D. Wade |
Novel human secreted proteins and polynucleotides encoding the same
|
US6720173B1
(en)
|
1999-11-08 |
2004-04-13 |
Lexicon Genetics Incorporated |
Human kinase protein and polynucleotides encoding the same
|
US6511840B1
(en)
|
2000-06-15 |
2003-01-28 |
Lexicon Genetics Incorporated |
Human kinase proteins and polynucleotides encoding the same
|
US6864079B2
(en)
|
2001-04-06 |
2005-03-08 |
Lexicon Genetics Incorporated |
Human kinase and polynucleotides encoding the same
|
US6797510B1
(en)
*
|
2001-05-24 |
2004-09-28 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US6841377B1
(en)
*
|
2001-06-13 |
2005-01-11 |
Lexicon Genetics Incorporated |
Human kinase and polynucleotides encoding the same
|
US6541252B1
(en)
|
2000-05-19 |
2003-04-01 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US6900045B2
(en)
*
|
2000-08-31 |
2005-05-31 |
Lexicon Genetics Incorporated |
Human kinase proteins and polynucleotides encoding the same
|
US6586230B1
(en)
*
|
2000-10-27 |
2003-07-01 |
Lexicon Genetics Incorporated |
Human kinase and polynucleotides encoding the same
|
US6593125B2
(en)
|
2000-11-20 |
2003-07-15 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US20080050809A1
(en)
*
|
1999-09-28 |
2008-02-28 |
Alejandro Abuin |
Novel human kinases and polynucleotides encoding the same
|
US20080213878A1
(en)
*
|
1999-10-19 |
2008-09-04 |
Gregory Donoho |
Novel human membrane proteins and polynucleotides encoding the same
|
WO2001034779A2
(en)
|
1999-11-12 |
2001-05-17 |
Lexicon Genetics Incorporated |
Human proteins with homology to carboxypeptidases and polynucleotides encoding the same
|
WO2001036469A2
(en)
*
|
1999-11-19 |
2001-05-25 |
Lexicon Genetics Incorporated |
Human ceruloplasmin
|
WO2001042287A2
(en)
*
|
1999-12-07 |
2001-06-14 |
Lexicon Genetics Incorporated |
Putative human g-protein coupled receptors
|
CA2393332A1
(en)
*
|
1999-12-07 |
2001-06-14 |
Lexicon Genetics Incorporated |
Novel human kinase proteins and polynucleotides encoding the same
|
JP2003516150A
(ja)
*
|
1999-12-08 |
2003-05-13 |
ジェンセット |
潜在性分泌タンパク質をコードする全長ヒトcDNA
|
EP1235909A1
(en)
*
|
1999-12-09 |
2002-09-04 |
Lexicon Genetics Incorporated |
Human adam-ts proteases and polynucleotides encoding the same
|
EP1263966A1
(en)
*
|
1999-12-13 |
2002-12-11 |
Lexicon Genetics Incorporated |
Novel human transferase proteins and polynucleotides encoding the same
|
AU2092901A
(en)
*
|
1999-12-22 |
2001-07-03 |
Lexicon Genetics Incorporated |
Polynucleotides encoding human protease homologs
|
US20020045743A1
(en)
*
|
1999-12-22 |
2002-04-18 |
Walke D. Wade |
Novel human membrane proteins and polynucleotides encoding the same
|
EP1244795A1
(en)
*
|
2000-01-06 |
2002-10-02 |
Lexicon Genetics Incorporated |
Novel human proteases and polynucleotides encoding the same
|
CA2397789C
(en)
*
|
2000-01-18 |
2010-10-19 |
Lexicon Genetics Incorporated |
Novel human kinase protein and polynucleotides encoding the same
|
US20020077464A1
(en)
*
|
2000-01-26 |
2002-06-20 |
Turner C. Alexander |
Novel human neurexin-like proteins and polynucleotides encoding the same
|
CA2398087A1
(en)
*
|
2000-01-28 |
2001-12-13 |
Lexicon Genetics Incorporated |
Novel human enzymes and polynucleotides encoding the same
|
US20020115837A1
(en)
*
|
2000-01-28 |
2002-08-22 |
Turner C. Alexander |
Novel human membrane proteins and polynucleotides encoding the same
|
CA2399663A1
(en)
*
|
2000-02-04 |
2001-08-09 |
Lexicon Genetics Incorporated |
Novel human enzymes and polynucleotides encoding the same
|
ATE438660T1
(de)
*
|
2000-02-04 |
2009-08-15 |
Lexicon Pharmaceuticals Inc |
Neue menschliche g-protein gekoppelten rezeptoren und dafür kodierende polynucleotide
|
CA2399876A1
(en)
|
2000-02-11 |
2001-08-16 |
Lexicon Genetics Incorporated |
Human proteases and polynucleotides encoding the same
|
AU2001238503A1
(en)
*
|
2000-02-17 |
2001-08-27 |
Lexicon Genetics Incorporated |
Novel human thrombospondin repeat proteins and polynucleotides encoding the same
|
EP1259610A2
(en)
*
|
2000-02-29 |
2002-11-27 |
Lexicon Genetics Incorporated |
Human transporter proteins and polynucleotides encoding the same
|
WO2001064903A2
(en)
|
2000-02-29 |
2001-09-07 |
Lexicon Genetics Incorporated |
Novel human transferase proteins and polynucleotides encoding the same
|
WO2001066744A2
(en)
*
|
2000-03-06 |
2001-09-13 |
Lexicon Genetics Incorporated |
Human transporter proteins and polynucleotides encoding the same
|
AU2001243521B2
(en)
*
|
2000-03-10 |
2006-08-24 |
Lexicon Pharmaceuticals, Inc. |
Novel human g-coupled protein receptor kinases and polynucleotides encoding the same
|
AU4739501A
(en)
*
|
2000-03-13 |
2001-09-24 |
Lexicon Genetics Inc |
Novel human phospholipases and polynucleotides encoding the same
|
CA2403636A1
(en)
*
|
2000-03-20 |
2001-09-27 |
Lexicon Genetics Incorporated |
Human secreted proteins and polynucleotides encoding the same
|
ATE366261T1
(de)
*
|
2000-03-28 |
2007-07-15 |
Lexicon Genetics Inc |
Humane 7-transmembranproteine und dafür codierende polynukleotide
|
CA2404896A1
(en)
*
|
2000-04-03 |
2001-10-11 |
Lexicon Genetics Incorporated |
Human ion channel protein and polynucleotides encoding the same
|
EP1276873A2
(en)
|
2000-04-25 |
2003-01-22 |
Lexicon Genetics Incorporated |
Human kinase proteins and polynucleotides encoding the same
|
EP1278512A2
(en)
*
|
2000-05-03 |
2003-01-29 |
MBT Munich Biotechnology AG |
Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites
|
US20020012651A1
(en)
*
|
2000-05-10 |
2002-01-31 |
Loeb Marvin P. |
Release of therapeutic agents in a vessel or tissue
|
EP1280909A2
(en)
*
|
2000-05-12 |
2003-02-05 |
Lexicon Genetics Incorporated |
Human lipocalin homologs and polynucleotides encoding the same
|
WO2001088133A2
(en)
*
|
2000-05-18 |
2001-11-22 |
Lexicon Genetics Incorporated |
Human semaphorin homologs and polynucleotides encoding the same
|
US6790667B1
(en)
*
|
2000-05-30 |
2004-09-14 |
Lexicon Genetics Incorporated |
Human mitochondrial proteins and polynucleotides encoding the same
|
US6703495B2
(en)
*
|
2000-06-07 |
2004-03-09 |
Lexicon Genetics Incorporated |
Polynucleotides encoding human transporter protein
|
EP1297134A2
(en)
*
|
2000-06-27 |
2003-04-02 |
Lexicon Genetics Incorporated |
Novel human gaba receptors and polynucleotides encoding the same
|
EP1315800A2
(en)
*
|
2000-07-21 |
2003-06-04 |
Incyte Genomics, Inc. |
Human proteases
|
US6887685B1
(en)
*
|
2000-07-25 |
2005-05-03 |
Lexicon Genetics Incorporated |
Human thymosin protein and polynucleotides encoding the same
|
US20020076780A1
(en)
*
|
2000-08-16 |
2002-06-20 |
Turner C. Alexander |
Novel human ion channel proteins and polynucleotides encoding the same
|
CA2420036A1
(en)
*
|
2000-08-22 |
2002-02-28 |
Lexicon Genetics Incorporated |
Human 7tm proteins and polynucleotides encoding the same
|
JP2004531201A
(ja)
*
|
2000-08-22 |
2004-10-14 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒトプロテアーゼ及び該プロテアーゼをコードするポリヌクレオチド
|
WO2002020753A2
(en)
*
|
2000-09-01 |
2002-03-14 |
Lexicon Genetics Incorporated |
Human gaba transporter protein and polynucleotides encoding the same
|
KR100381512B1
(ko)
|
2000-09-21 |
2003-04-26 |
굿젠 주식회사 |
유전자 및 생물학적 활성 약물 전달용 양이온성 지질과이의 용도
|
WO2002026980A2
(en)
|
2000-09-27 |
2002-04-04 |
Lexicon Genetics Incorporated |
Human ion-exchanger proteins and polynucleotides encoding t he same
|
US6777232B1
(en)
*
|
2000-10-02 |
2004-08-17 |
Lexicon Genetics Incorporated |
Human membrane proteins and polynucleotides encoding the same
|
DE60132670T2
(de)
*
|
2000-10-12 |
2009-02-05 |
The University Of Medicine And Dentistry Of New Jersey |
Oligonukleotid-unterstützte koaleszenz
|
WO2002031129A2
(en)
|
2000-10-12 |
2002-04-18 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US7001763B1
(en)
|
2000-10-17 |
2006-02-21 |
Lexicon Genetics Incorporated |
Human semaphorin proteins and polynucleotides encoding the same
|
JP2004533221A
(ja)
*
|
2000-10-27 |
2004-11-04 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒト7tmタンパクおよびそれをコードするポリヌクレオチド
|
CA2427701A1
(en)
*
|
2000-10-30 |
2002-05-10 |
Lexicon Genetics Incorporated |
Human 7tm proteins and polynucleotides encoding the same
|
EP1341906A2
(en)
|
2000-12-11 |
2003-09-10 |
Lexicon Genetics Incorporated |
Novel human kinase and polynucleotides encoding the same
|
JP2004530417A
(ja)
|
2000-12-12 |
2004-10-07 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒトキナーゼおよびそれをコードするポリヌクレオチド
|
US20020073441A1
(en)
|
2000-12-13 |
2002-06-13 |
Ross Brian D. |
Compositions and methods for detecting proteolytic activity
|
US6583269B1
(en)
|
2000-12-18 |
2003-06-24 |
Lexicon Genetics Incorporated |
Human protease inhibitor and polynucleotides encoding the same
|
US6852844B1
(en)
*
|
2000-12-20 |
2005-02-08 |
Lexicon Genetics Incorporated |
Human protocadherin proteins and polynucleotides encoding the same
|
CA2432737A1
(en)
*
|
2000-12-20 |
2002-06-27 |
Lexicon Genetics Incorporated |
Human ion channel protein and polynucleotides encoding the same
|
AU2002246858A1
(en)
*
|
2000-12-27 |
2002-08-06 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
AU2001297533A1
(en)
*
|
2000-12-28 |
2002-09-12 |
Lexicon Genetics Incorporated |
Novel human ion channel-related proteins and polynucleotides encoding the same
|
US20020115844A1
(en)
*
|
2001-01-05 |
2002-08-22 |
Yu Xuanchuan Sean |
Novel human lipase and polynucleotides encoding the same
|
JP2004524835A
(ja)
*
|
2001-01-23 |
2004-08-19 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒトキナーゼおよびそれをコードするポリヌクレオチド
|
US20020115846A1
(en)
*
|
2001-01-24 |
2002-08-22 |
Xuanchuan (Sean) Yu |
Novel human lipase and polynucleotides encoding the same
|
US20020127674A1
(en)
*
|
2001-02-02 |
2002-09-12 |
Xuanchuan Yu |
Novel human transporter protein and polynucleotides encoding the same
|
EP1355657A2
(en)
*
|
2001-02-02 |
2003-10-29 |
Genset |
Gssp3 polynucleotides and polypeptides and uses thereof
|
CA2473197A1
(en)
*
|
2001-02-20 |
2002-08-29 |
Lexicon Genetics Incorporated |
Novel human protease and polynucleotides encoding the same
|
JP3929250B2
(ja)
*
|
2001-03-08 |
2007-06-13 |
株式会社ルネサステクノロジ |
半導体装置
|
US7252990B2
(en)
|
2001-03-12 |
2007-08-07 |
Lexicon Genetics Incorporated |
Human dectin proteins and polynucleotides encoding the same
|
WO2002072611A2
(en)
*
|
2001-03-12 |
2002-09-19 |
Lexicon Genetics Incorporated |
Novel human egf-family proteins and polynucleotides encoding the same
|
US20020164627A1
(en)
*
|
2001-03-12 |
2002-11-07 |
Wilganowski Nathaniel L. |
Novel human transporter proteins and polynucleotides encoding the same
|
US6994995B1
(en)
|
2001-03-16 |
2006-02-07 |
Lexicon Genetics Incorporated |
Human synaptotagmin and polynucleotides encoding the same
|
WO2002074932A2
(en)
|
2001-03-20 |
2002-09-26 |
Lexicon Genetics Incorporated |
Novel human kinase and polynucleotides encoding the same
|
US20030096414A1
(en)
|
2001-03-27 |
2003-05-22 |
Invitrogen Corporation |
Culture medium for cell growth and transfection
|
EP1383879A4
(en)
*
|
2001-04-06 |
2005-05-11 |
Lexicon Genetics Inc |
HUMAN KINASES AND POLYNUCLEOTIDES ENCODING SAME
|
US6644173B2
(en)
*
|
2001-04-11 |
2003-11-11 |
Keuring, Incorporated |
Beverage filter cartridge holder
|
WO2002083706A1
(en)
*
|
2001-04-16 |
2002-10-24 |
Lexicon Genetics Incorporated |
Nucleic acid encoding a human adenylosuccinate synthetase
|
US20030166893A1
(en)
*
|
2001-04-30 |
2003-09-04 |
Yi Hu |
Novel human nuclear transporters and polynucleotides encoding the same
|
JP2004537986A
(ja)
*
|
2001-05-09 |
2004-12-24 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規キナーゼおよびそれをコードするポリヌクレオチド
|
US20020193585A1
(en)
*
|
2001-05-25 |
2002-12-19 |
Walke D. Wade |
Novel human transporter proteins and polynucleotides encoding the same
|
JP2005500829A
(ja)
|
2001-05-29 |
2005-01-13 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒト水酸化酵素及び該酵素をコードするポリヌクレオチド
|
JP2004531268A
(ja)
*
|
2001-06-14 |
2004-10-14 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒトトランスポータータンパクおよびそれをコードするポリヌクレオチド
|
JP2005500060A
(ja)
*
|
2001-08-14 |
2005-01-06 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒトコラーゲンタンパクおよびそれをコードするポリヌクレオチド
|
EP1441763A2
(en)
*
|
2001-11-07 |
2004-08-04 |
Inex Pharmaceuticals Corp. |
Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
|
CA2471967A1
(en)
*
|
2002-01-03 |
2003-07-31 |
Board Of Regents, The University Of Texas System |
Wt1 antisense oligos for the inhibition of breast cancer
|
US20030220284A1
(en)
*
|
2002-02-22 |
2003-11-27 |
Patricia Yotnda |
Delivery of adenoviral DNA in a liposomal formulation for treatment of disease
|
EP3100719A3
(en)
*
|
2002-05-15 |
2017-02-22 |
California Pacific Medical Center |
Delivery of nucleic acid-like compounds
|
US20040016013A1
(en)
*
|
2002-07-18 |
2004-01-22 |
Gonzalo Hortelano |
Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent
|
US20040014698A1
(en)
*
|
2002-07-18 |
2004-01-22 |
Gonzalo Hortelano |
Oral administration of therapeutic agent coupled to transporting agent
|
US20040014704A1
(en)
*
|
2002-07-18 |
2004-01-22 |
Gonzalo Hortelano |
Oral administration of therapeutic agent coupled to transporting agent induces tolerance
|
JP3447009B1
(ja)
*
|
2002-10-29 |
2003-09-16 |
實 平垣 |
構築物用構成体およびその製造方法
|
US20040115226A1
(en)
*
|
2002-12-12 |
2004-06-17 |
Wenji Li |
Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same
|
AU2004204456A1
(en)
*
|
2003-01-09 |
2004-07-29 |
Invitrogen Corporation |
Cellular delivery and activation polypeptide-nucleic acid complexes
|
US20040248850A1
(en)
*
|
2003-02-11 |
2004-12-09 |
Kemia, Inc. |
Compounds for the treatment of HIV infection
|
US20040167090A1
(en)
*
|
2003-02-21 |
2004-08-26 |
Monahan Sean D. |
Covalent modification of RNA for in vitro and in vivo delivery
|
US20050208032A1
(en)
*
|
2004-01-16 |
2005-09-22 |
Gonzalo Hortelano |
Oral administration of therapeutic agent coupled to transporting agent
|
US20050238675A1
(en)
*
|
2004-04-26 |
2005-10-27 |
Wenjie Li |
Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications
|
EP1766389A4
(en)
|
2004-05-12 |
2008-08-27 |
Inst Medical W & E Hall |
CELL ISOLATION PROCEDURE
|
WO2006065960A2
(en)
*
|
2004-12-14 |
2006-06-22 |
Applera Corporation |
Cationic liposomes comprising a charge neutral compound and a cationic phospholipid
|
CA2613480C
(en)
|
2005-06-24 |
2015-10-20 |
The Walter And Eliza Hall Institute Of Medical Research |
Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same
|
US7312079B1
(en)
|
2005-10-06 |
2007-12-25 |
Lexicon Pharmaceuticals, Inc. |
Variants of FAM3C
|
US20070087045A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Industrial Technology Research Institute |
Lipid carrier and method of preparing the same
|
JP5336853B2
(ja)
|
2005-11-02 |
2013-11-06 |
プロチバ バイオセラピューティクス インコーポレイティッド |
修飾siRNA分子およびその使用法
|
WO2007070705A2
(en)
*
|
2005-12-15 |
2007-06-21 |
The Trustees Of The University Of Pennsylvania |
Cationic lipid-mediated vectors
|
WO2007082352A1
(en)
|
2006-01-20 |
2007-07-26 |
Child Health Research Institute Inc |
Method of treatment, prophylaxis and diagnosis of pathologies of the bone
|
US20080004410A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Yu-Chin Lai |
Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
|
US20080009072A1
(en)
*
|
2006-07-07 |
2008-01-10 |
Cytyc Corporation |
Ultrasonic mixing of a biological sample
|
US8664364B2
(en)
|
2007-01-24 |
2014-03-04 |
Carnegie Mellon University |
Optical biosensors
|
ES2534490T3
(es)
|
2007-08-02 |
2015-04-23 |
Gilead Biologics, Inc. |
Inhibidores de LOX y LOXL2 y usos de los mismos
|
WO2009082817A1
(en)
|
2007-12-27 |
2009-07-09 |
Protiva Biotherapeutics, Inc. |
Silencing of polo-like kinase expression using interfering rna
|
WO2009114538A1
(en)
*
|
2008-03-10 |
2009-09-17 |
Evgueni Pinkhassik |
Aminophosphonate carriers for liposome-based drug release systems
|
EP2281041B1
(en)
|
2008-04-15 |
2014-07-02 |
Protiva Biotherapeutics Inc. |
Silencing of csn5 gene expression using interfering rna
|
JP2011520962A
(ja)
*
|
2008-05-19 |
2011-07-21 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
新規カチオン性脂質を含む方法及び組成物
|
US9249189B2
(en)
|
2010-01-18 |
2016-02-02 |
Albany Medical College |
Alpha-fetoprotein “ring and tail” peptides
|
CA2802994A1
(en)
|
2010-06-17 |
2011-12-22 |
The United States Of America As Represented By The Secretary, National I Nstitutes Of Health |
Compositions and methods for treating inflammatory conditions
|
US10849975B2
(en)
|
2011-02-03 |
2020-12-01 |
Thomas Jefferson University |
Multivalent vaccines for rabies virus and filoviruses
|
JP6054308B2
(ja)
|
2011-02-15 |
2016-12-27 |
メリマック ファーマシューティカルズ, インコーポレイテッドMerrimack Pharmaceuticals, Inc. |
核酸を細胞へ送達する組成物及び方法
|
EP2694660B1
(en)
|
2011-04-03 |
2018-08-08 |
The General Hospital Corporation |
Efficient protein expression in vivo using modified rna (mod-rna)
|
SG10201804809RA
(en)
|
2011-08-22 |
2018-07-30 |
Cnj Holdings Inc |
Clostridium difficile antibodies
|
WO2013075132A1
(en)
|
2011-11-17 |
2013-05-23 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Therapeutic rna switches compositions and methods of use
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
CN104884065B
(zh)
|
2012-09-21 |
2019-01-01 |
强烈治疗剂公司 |
治疗癌症的方法
|
US20160367638A1
(en)
|
2013-12-19 |
2016-12-22 |
Crystal BYERS |
LEPTIN mRNA COMPOSITIONS AND FORMULATIONS
|
US20170065702A1
(en)
|
2014-02-19 |
2017-03-09 |
Cangene Corporation |
Methods of modulating an immune response
|
BR112016028750A2
(pt)
|
2014-06-11 |
2017-11-14 |
Gilead Sciences Inc |
?métodos para tratar, prevenir, ou melhorar pelo menos um sintoma associado e para diagnosticar e monitorar insuficiência cardíaca ou fibrilação atrial, inibidor da lisil oxidase ativa ou proteína lisil tipo oxidase, e, composição?
|
WO2016011203A1
(en)
|
2014-07-15 |
2016-01-21 |
Life Technologies Corporation |
Compositions with lipid aggregates and methods for efficient delivery of molecules to cells
|
CN107208095B
(zh)
|
2014-10-02 |
2021-11-16 |
阿布特斯生物制药公司 |
用于使乙型肝炎病毒基因表达沉默的组合物和方法
|
AU2016246057A1
(en)
|
2015-04-09 |
2017-11-02 |
Bikanta Corporation |
Imaging systems and methods using fluorescent nanodiamonds
|
US20180245074A1
(en)
|
2015-06-04 |
2018-08-30 |
Protiva Biotherapeutics, Inc. |
Treating hepatitis b virus infection using crispr
|
EP3329003A2
(en)
|
2015-07-29 |
2018-06-06 |
Arbutus Biopharma Corporation |
Compositions and methods for silencing hepatitis b virus gene expression
|
ES2887602T3
(es)
|
2015-09-04 |
2021-12-23 |
Primatope Therapeutics Inc |
Anticuerpos anti-CD40 humanizados y usos de los mismos
|
KR20180063885A
(ko)
|
2015-09-24 |
2018-06-12 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
전이 감소를 위한 방법 및 조성물
|
US10149887B2
(en)
|
2015-10-23 |
2018-12-11 |
Canbas Co., Ltd. |
Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment
|
US20170360815A1
(en)
|
2016-02-25 |
2017-12-21 |
Applied Biological Laboratories, Inc. |
Compositions and methods for protecting against airborne pathogens and irritants
|
KR20180120204A
(ko)
|
2016-02-25 |
2018-11-05 |
어플라이드 바이올로지컬 래버러토리즈 인코포레이티드 |
공기 매개 병원체 및 자극물질에 대한 보호용 조성물 및 방법
|
EP3439695B1
(en)
|
2016-04-04 |
2022-05-04 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Multivalent vaccines for rabies virus and coronaviruses
|
TWI788307B
(zh)
|
2016-10-31 |
2023-01-01 |
美商艾歐凡斯生物治療公司 |
用於擴增腫瘤浸潤性淋巴細胞之工程化人造抗原呈現細胞
|
WO2018232079A1
(en)
|
2017-06-14 |
2018-12-20 |
Daley George Q |
Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells by episomal plasmid gene transfer
|
US20200277573A1
(en)
|
2017-11-17 |
2020-09-03 |
Iovance Biotherapeutics, Inc. |
Til expansion from fine needle aspirates and small biopsies
|
JP2021503885A
(ja)
|
2017-11-22 |
2021-02-15 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
末梢血からの末梢血リンパ球(pbl)の拡大培養
|
US20220204932A1
(en)
|
2018-01-08 |
2022-06-30 |
Iovance Biotherapeutics, Inc. |
Processes for generating til products enriched for tumor antigen-specific t-cells
|
US11713446B2
(en)
|
2018-01-08 |
2023-08-01 |
Iovance Biotherapeutics, Inc. |
Processes for generating TIL products enriched for tumor antigen-specific T-cells
|
WO2019136459A1
(en)
|
2018-01-08 |
2019-07-11 |
Iovance Biotherapeutics, Inc. |
Processes for generating til products enriched for tumor antigen-specific t-cells
|
SG11202010319RA
(en)
|
2018-04-27 |
2020-11-27 |
Iovance Biotherapeutics Inc |
Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
JP2022512899A
(ja)
|
2018-11-05 |
2022-02-07 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
抗pd-1抗体に対して不応性のnsclc患者の治療
|
MX2021004775A
(es)
|
2018-11-05 |
2021-06-08 |
Iovance Biotherapeutics Inc |
Expansion de linfocitos infiltrantes de tumores (tils) usando inhibidores de la via de proteina cinasa b (akt).
|
JP2022512915A
(ja)
|
2018-11-05 |
2022-02-07 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
改良された腫瘍反応性t細胞の選択
|
EP3877513A2
(en)
|
2018-11-05 |
2021-09-15 |
Iovance Biotherapeutics, Inc. |
Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
CA3123392A1
(en)
|
2018-12-19 |
2020-06-25 |
Iovance Biotherapeutics, Inc. |
Methods of expanding tumor infiltrating lymphocytes using engineered cytokine receptor pairs and uses thereof
|
WO2020180733A1
(en)
|
2019-03-01 |
2020-09-10 |
Iovance Biotherapeutics, Inc. |
Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof
|
WO2020232029A1
(en)
|
2019-05-13 |
2020-11-19 |
Iovance Biotherapeutics, Inc. |
Methods and compositions for selecting tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
JP2022553389A
(ja)
|
2019-10-25 |
2022-12-22 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
腫瘍浸潤リンパ球の遺伝子編集及び免疫療法におけるその使用
|
EP4073236A1
(en)
|
2019-12-11 |
2022-10-19 |
Iovance Biotherapeutics, Inc. |
Processes for the production of tumor infiltrating lymphocytes (tils) and methods of using the same
|
CA3177413A1
(en)
|
2020-05-04 |
2021-11-11 |
Michelle SIMPSON-ABELSON |
Selection of improved tumor reactive t-cells
|
CA3176826A1
(en)
|
2020-05-04 |
2021-11-11 |
Iovance Biotherapeutics, Inc. |
Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
US20230372397A1
(en)
|
2020-10-06 |
2023-11-23 |
Iovance Biotherapeutics, Inc. |
Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
|
WO2022076606A1
(en)
|
2020-10-06 |
2022-04-14 |
Iovance Biotherapeutics, Inc. |
Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
|
TW202241468A
(zh)
|
2020-12-11 |
2022-11-01 |
美商艾歐凡斯生物治療公司 |
用腫瘤浸潤性淋巴球療法與braf抑制劑及/或mek抑制劑組合治療癌症患者
|
CA3202483A1
(en)
|
2020-12-17 |
2022-06-23 |
Maria Fardis |
Treatment with tumor infiltrating lymphocyte therapies in combination with ctla-4 and pd-1 inhibitors
|
WO2022133149A1
(en)
|
2020-12-17 |
2022-06-23 |
Iovance Biotherapeutics, Inc. |
Treatment of cancers with tumor infiltrating lymphocytes
|
JP2024506557A
(ja)
|
2021-01-29 |
2024-02-14 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
修飾された腫瘍浸潤リンパ球を作製する方法及び養子細胞療法におけるそれらの使用
|
US20240191191A1
(en)
|
2021-03-19 |
2024-06-13 |
Iovance Biotherapeutics, Inc. |
Methods for infiltrating lymphocyte (til) expansion related to cd39/cd69 selection and gene knockout in tils
|
WO2022204155A1
(en)
|
2021-03-23 |
2022-09-29 |
Iovance Biotherapeutics, Inc. |
Cish gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
KR20240037185A
(ko)
|
2021-04-19 |
2024-03-21 |
이오반스 바이오테라퓨틱스, 인크. |
키메라 공동자극 수용체, 케모카인 수용체, 및 세포 면역치료에서의 이의 용도
|
EP4340850A1
(en)
|
2021-05-17 |
2024-03-27 |
Iovance Biotherapeutics, Inc. |
Pd-1 gene-edited tumor infiltrating lymphocytes and uses of same in immunotherapy
|
CA3226111A1
(en)
|
2021-07-22 |
2023-01-26 |
Iovance Biotherapeutics, Inc. |
Method for cryopreservation of solid tumor fragments
|
TW202327631A
(zh)
|
2021-07-28 |
2023-07-16 |
美商艾歐凡斯生物治療公司 |
利用腫瘤浸潤性淋巴球療法與kras抑制劑組合治療癌症患者
|
AU2022343729A1
(en)
|
2021-09-09 |
2024-03-21 |
Iovance Biotherapeutics, Inc. |
Processes for generating til products using pd-1 talen knockdown
|
AR127482A1
(es)
|
2021-10-27 |
2024-01-31 |
Iovance Biotherapeutics Inc |
Sistemas y métodos para coordinar la fabricación de células para inmunoterapia específica de paciente
|
CA3237410A1
(en)
|
2021-11-10 |
2023-05-19 |
Friedrich Graf Finck VON FINCKENSTEIN |
Methods of expansion treatment utilizing cd8 tumor infiltrating lymphocytes
|
WO2023147488A1
(en)
|
2022-01-28 |
2023-08-03 |
Iovance Biotherapeutics, Inc. |
Cytokine associated tumor infiltrating lymphocytes compositions and methods
|
WO2023147486A1
(en)
|
2022-01-28 |
2023-08-03 |
Iovance Biotherapeutics, Inc. |
Tumor infiltrating lymphocytes engineered to express payloads
|
WO2023196877A1
(en)
|
2022-04-06 |
2023-10-12 |
Iovance Biotherapeutics, Inc. |
Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
|
WO2023201369A1
(en)
|
2022-04-15 |
2023-10-19 |
Iovance Biotherapeutics, Inc. |
Til expansion processes using specific cytokine combinations and/or akti treatment
|
WO2023220608A1
(en)
|
2022-05-10 |
2023-11-16 |
Iovance Biotherapeutics, Inc. |
Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with an il-15r agonist
|
WO2024030758A1
(en)
|
2022-08-01 |
2024-02-08 |
Iovance Biotherapeutics, Inc. |
Chimeric costimulatory receptors, chemokine receptors, and the use of same in cellular immunotherapies
|
WO2024055018A1
(en)
|
2022-09-09 |
2024-03-14 |
Iovance Biotherapeutics, Inc. |
Processes for generating til products using pd-1/tigit talen double knockdown
|
WO2024055017A1
(en)
|
2022-09-09 |
2024-03-14 |
Iovance Biotherapeutics, Inc. |
Processes for generating til products using pd-1/tigit talen double knockdown
|
WO2024098024A1
(en)
|
2022-11-04 |
2024-05-10 |
Iovance Biotherapeutics, Inc. |
Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof
|
WO2024098027A1
(en)
|
2022-11-04 |
2024-05-10 |
Iovance Biotherapeutics, Inc. |
Methods for tumor infiltrating lymphocyte (til) expansion related to cd39/cd103 selection
|
WO2024112571A2
(en)
|
2022-11-21 |
2024-05-30 |
Iovance Biotherapeutics, Inc. |
Two-dimensional processes for the expansion of tumor infiltrating lymphocytes and therapies therefrom
|
WO2024112711A2
(en)
|
2022-11-21 |
2024-05-30 |
Iovance Biotherapeutics, Inc. |
Methods for assessing proliferation potency of gene-edited t cells
|
WO2024118836A1
(en)
|
2022-11-30 |
2024-06-06 |
Iovance Biotherapeutics, Inc. |
Processes for production of tumor infiltrating lymphocytes with shortened rep step
|